213 related articles for article (PubMed ID: 34785642)
1. UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma.
Gui L; Zhang S; Xu Y; Zhang H; Zhu Y; Kong L
Cell Death Discov; 2021 Nov; 7(1):357. PubMed ID: 34785642
[TBL] [Abstract][Full Text] [Related]
2. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
[TBL] [Abstract][Full Text] [Related]
3. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus Downregulates Ubiquitin-Conjugating Enzyme E2S Expression To Prevent Proteasomal Degradation of NS5A, Leading to Host Cells More Sensitive to DNA Damage.
Pham HT; Nguyen TTT; Nguyen LP; Han SS; Lim YS; Hwang SB
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381483
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
[TBL] [Abstract][Full Text] [Related]
6. [High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
Chen H; Li Z; Wang M; Lu L; Tang Q; Luo L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):455-464. PubMed ID: 38597436
[TBL] [Abstract][Full Text] [Related]
7. UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1.
Tang H; Fang T; Ji M; Wang JP; Song LL; Zhang QY; Wu JS
Biochem Biophys Res Commun; 2021 Nov; 578():7-14. PubMed ID: 34520980
[TBL] [Abstract][Full Text] [Related]
8. UBE2S is associated with malignant characteristics of breast cancer cells.
Ayesha AK; Hyodo T; Asano E; Sato N; Mansour MA; Ito S; Hamaguchi M; Senga T
Tumour Biol; 2016 Jan; 37(1):763-72. PubMed ID: 26245992
[TBL] [Abstract][Full Text] [Related]
9. Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis.
Zhang CY; Yang M
World J Hepatol; 2022 May; 14(5):956-971. PubMed ID: 35721293
[TBL] [Abstract][Full Text] [Related]
10. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.
Zhang RY; Liu ZK; Wei D; Yong YL; Lin P; Li H; Liu M; Zheng NS; Liu K; Hu CX; Yang XZ; Chen ZN; Bian H
Signal Transduct Target Ther; 2021 Feb; 6(1):64. PubMed ID: 33589597
[TBL] [Abstract][Full Text] [Related]
11. Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.
Liess AKL; Kucerova A; Schweimer K; Schlesinger D; Dybkov O; Urlaub H; Mansfeld J; Lorenz S
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082289
[TBL] [Abstract][Full Text] [Related]
12. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
13. Knockout of UBE2S inhibits the proliferation of gastric cancer cells and induces apoptosis by FAS-mediated death receptor pathway.
Zhao R; Yu Z; Mao X; Zheng Y; Wang Y; Zhou Y
Exp Cell Res; 2022 Oct; 419(1):113293. PubMed ID: 35863455
[TBL] [Abstract][Full Text] [Related]
14. UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer.
Lin M; Lei T; Zheng J; Chen S; Du L; Xie H
Int J Biochem Cell Biol; 2019 Apr; 109():17-22. PubMed ID: 30690078
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
16. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
[TBL] [Abstract][Full Text] [Related]
17. Autoinhibition Mechanism of the Ubiquitin-Conjugating Enzyme UBE2S by Autoubiquitination.
Liess AKL; Kucerova A; Schweimer K; Yu L; Roumeliotis TI; Diebold M; Dybkov O; Sotriffer C; Urlaub H; Choudhary JS; Mansfeld J; Lorenz S
Structure; 2019 Aug; 27(8):1195-1210.e7. PubMed ID: 31230944
[TBL] [Abstract][Full Text] [Related]
18. Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms.
Zhang M; Wang J; Zhang Z; Guo Y; Lou X; Zhang L
Heliyon; 2024 Jan; 10(2):e24465. PubMed ID: 38312603
[TBL] [Abstract][Full Text] [Related]
19. A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective.
Bao H; Luo Y; Ding G; Fu Z
J Oncol; 2022; 2022():3982539. PubMed ID: 35578600
[TBL] [Abstract][Full Text] [Related]
20. Ube2s expression is elevated in hepatocellular carcinoma and predicts poor prognosis of the patients.
Li Q; Zhao Y; Shi X; Fan C
Int J Clin Exp Pathol; 2018; 11(2):781-787. PubMed ID: 31938165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
